BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 597475)

  • 1. Effect of Corynebacterium parvum on peripheral blood platelets.
    Jones PD; Sadler TE; Castro JE
    Br J Cancer; 1977 Dec; 36(6):777-82. PubMed ID: 597475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases.
    Sadler TE; Castro JE
    Br J Surg; 1976 Apr; 63(4):292-6. PubMed ID: 1276661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabelling of Corynebacterium parvum and its distribution in mice.
    Sadler TE; Cramp WA; Castro JE
    Br J Cancer; 1977 Mar; 35(3):357-68. PubMed ID: 851511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
    Karrer K; Rella W; Goldin A
    Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of Corynebacterium parvum and cortisone on the primary Lewis tumour and its metastases.
    Jones PD; Sadler TE; Castro JE
    Int J Cancer; 1978 Jun; 21(6):784-8. PubMed ID: 669856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and mode of action of Corynebacterium parvum on murine tumour metastases.
    Castro JE; Sadler TE; Jones PD
    Dev Biol Stand; 1977 Apr 13-15; 38():277-81. PubMed ID: 608510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amputation and Corynebacterium parvum on tumour metastases in mice.
    Mosley JG; Sadler TE; Castro JE
    Br J Cancer; 1978 Apr; 37(4):571-5. PubMed ID: 646927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
    Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
    Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF; Whitehead VL; Speedy G
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
    Yuhas JM; Ullrich RL
    Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single versus multiple human-equivalent doses of C. parvum in mice: neutralization of the anti-metastatic effect.
    Mitcheson HD; Sadler TE; Castro JE
    Br J Cancer; 1980 Mar; 41(3):407-14. PubMed ID: 7387830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
    Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
    Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Corynebacterium parvum on tumour metastases in mice.
    Castro JE
    Br J Surg; 1977 Oct; 64(10):721-4. PubMed ID: 922293
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in anatomical distribution of tumour lesions induced by platelet-active drugs.
    Willmott N; Malcolm A; McLeod T; Gracie A; Calman KC
    Invasion Metastasis; 1983; 3(1):32-51. PubMed ID: 6677619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of preoperative C. parvum vaccine to modify secondary disease following excision of two non-immunogenic murine carcinomas.
    Hewitt HB; Blake ER
    Br J Cancer; 1978 Aug; 38(2):219-23. PubMed ID: 698036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopotentiation of cell-mediated hypersensitivity by Corynebacterium parvum (Propionibacterium acnes).
    Maguire HC; Cipriano D
    Int Arch Allergy Appl Immunol; 1983; 70(1):34-9. PubMed ID: 6848475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
    Scott MT; Milas L
    Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of 3H-thymidine-labelled C. parvum in mice.
    Sadler TE; Cramp WA; Castro JE
    Dev Biol Stand; 1977 Apr 13-15; 38():137-43. PubMed ID: 608501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Treatment of a metastasizing murine tumour with Corynebacterium parvum.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Feb; 31(2):264. PubMed ID: 1164486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.